In 1996, the City of Aurora and University of Colorado worked together to create a special-purpose entity called the Fitzsimons Redevelopment Authority (FRA). The FR single mission: to imagine and govern the evolution of a historic army medical center into one of the world’s most forward-looking bioscience districts. The top community leaders on the FRA board of directors are dedicated to this vision for the Fitzsimons Life Science District. In partnership with the University of Colorado, the City of Aurora, The Children’s Hospital and other public entities, the FRA acquired much of the Fitzsimons site and began to implement an ambitious redevelopment plan.
The Fitzsimons Redevelopment Authority directs the commercial developments in the District, along with its partner, Forest City Science + Technology Group. In this role, the FRA is dedicated to providing life science companies: an environment where they can thrive; success-enhancing resources like the District’s incubator facilities; and services that help form connections between private industry and the University of Colorado.
The result? Aurora’s Fitzsimons Life Science District is becoming what its founders envisioned: a functioning community that directly supports the health and well-being of life science companies.
Following an extensive national search, Fitzsimons Redevelopment Authority named Steve VanNurden as its new President and Chief Executive Officer in March 2012. He took over the office in late May 2012. The appointment of VanNurden is further evidence of the FRA's continued commitment to support the development of life science companies in Colorado in partnership with the State’s research institutions. He is working with universities, local economic development agencies, state and local governments, and the bioscience industry to promote the successful development of the 180 acre Colorado Science + Technology Park, which is adjacent to the University of Colorado’s Anschutz Medical Campus in Aurora.
VanNurden came to the FRA from Mayo Clinic Ventures, the invention arm for Mayo Clinic. Under his direction, this division was responsible for patenting and commercializing Mayo’s discoveries, inventions and other intellectual property. Under the guidance of VanNurden, Mayo’s technology based ventures efforts resulted in the formation of 45+ Mayo Clinic start-up companies. Prior to joining the Mayo Clinic, VanNurden’s industry experience included management positions at Cargill, Inc., US Bank, and Aerodrome Airline Services, Inc. VanNurden holds degrees in Accounting and Finance and a Masters Degree in Business Administration.
The FRA Board of Directors is made up of leaders in the bioscience industry, University of Colorado and the City of Aurora.
The Bioscience Park Center is literally across the street from Research Complex 2 at the Anschutz Medical Campus. Incubator tenants enjoy the proximity to world class university research and facilities.
For additional information about the FRA, please contact us at 720-859-4100.